Nicox S.A.
OTC: NICXF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Gavin Spencer
- Employees
- 28
- Headquarters
- Biot, France
- IPO year
- 2010
- Market cap
- $30.9M
- Website
- https://www.nicox.com
Loading NICXF…
Loading profile data…Frequently asked questions about NICXF
What does Nicox S.A. (NICXF) do?
Nicox S.A. is an international ophthalmic pharmaceutical company, headquartered in Valbonne, France, and established in 1996. Its core mission is to develop innovative treatments aimed at preserving sight and enhancing overall eye health. The company's primary investigational compound, NCX 470, a cutting-edge nitric oxide-donating prostaglandin...
Where does NICXF trade?
Nicox S.A. (NICXF) trades on the Other OTC.
What sector is NICXF in?
Nicox S.A. (NICXF) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Nicox S.A.?
Gavin Spencer is the chief executive officer of Nicox S.A. (NICXF).
Where is Nicox S.A. headquartered?
Nicox S.A. is headquartered in France.
Does NICXF pay a dividend?
Nicox S.A. (NICXF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did NICXF go public?
Nicox S.A. (NICXF) completed its initial public offering in 2010.